Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest update is out from OncoSil Medical Ltd ( (AU:OSL) ).
OncoSil Medical Ltd announced the cessation of 17,076 ordinary fully paid securities due to the lapse of conditional rights, as the conditions for these securities were not met or became incapable of being satisfied. This development may impact the company’s capital structure and could have implications for its financial strategy and stakeholder interests.
The most recent analyst rating on (AU:OSL) stock is a Sell with a A$1.00 price target. To see the full list of analyst forecasts on OncoSil Medical Ltd stock, see the AU:OSL Stock Forecast page.
More about OncoSil Medical Ltd
OncoSil Medical Ltd operates in the medical industry, focusing on developing and commercializing innovative medical devices for the treatment of cancer. The company is known for its products that aim to improve the quality of life for cancer patients, with a particular emphasis on targeted radiation therapy solutions.
Average Trading Volume: 23,666
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$19.95M
Find detailed analytics on OSL stock on TipRanks’ Stock Analysis page.